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ABSTRACT
Whole-transcriptome expression proﬁling provides novel phenotypes for analysis of complex traits. Gene expression measurements reﬂect
quantitative variation in transcript-speciﬁc messenger RNA levels and represent phenotypes lying close to the action of genes. Understanding the
genetic basis of gene expression will provide insight into the processes that connect genotype to clinically signiﬁcant traits representing a central
tenet of system biology. Synchronous in vivo expression proﬁles of lymphocytes, muscle, and subcutaneous fat were obtained from healthy Mexican
men. Most genes were expressed at detectable levels in multiple tissues, and RNA levels were correlated between tissue types. A subset of transcripts
with high reliability of expression across tissues (estimated by intraclass correlation coefﬁcients) was enriched for cis-regulated genes, suggesting that
proximal sequence variants may influence expression similarly in different cellular environments. This integrative global gene expression profiling
approach is proving extremely useful for identifying genes and pathways that contribute to complex clinical traits. Clearly, the coincidence of clinical
trait quantitative trait loci and expression quantitative trait loci can help in the prioritization of positional candidate genes. Such data will be crucial
for the formal integration of positional and transcriptomic information characterized as genetical genomics. Adv. Nutr. 3: 596S–604S, 2012.
Introduction
Quantitative variation in gene expression: the
expression phenotype
Normal variation in a complex phenotype, such as sus-
ceptibility to obesity and cardiovascular disease (CVD11), is
expected to be the result of variation in many genes. An im-
portant part of this variation is thought to be in the variability
in expression, especially in those genes that are highly con-
served (1). Many complex phenotypes, including CVD, are
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influenced by individual variation in expression of multiple
genes. In the past few years, positional genetics (linkage, asso-
ciation) and transcriptomic approaches have been brought
together to study the genetic control of gene expression itself
(2,3). This interest derives from the widely held view that
phenotypic diversity is at least as likely to come from variation
in the levels and/or timing of production of gene products as
from functional changes within the genes themselves (2,4).
Researchers have recently acquired genomewide expres-
sion proﬁles from nontransformed lymphocytes from 1240
individuals in the San Antonio Family Heart Study (SAFHS)
(5). Lymphocyte gene expression was analyzed in the Mexi-
can Americans participating in the SAFHS, and heritable var-
iation in expression of >16,000 autosomal genes was found.
At least 750 of these showed significant evidence of cis regu-
lation; that is, the strongest linkage signal in a genome scan of
each expression phenotype mapped to the physical location
of the expressed gene. This strongly suggests that, for these
genes, sequence variants in the structural loci are the primary
source of individual heritable variation in expression (6).
Identification of such variants (e.g., promoter variants)
should be especially straightforward, leading to detailed mo-
lecular genetic understanding of the sources of heritable var-
iation in expression of each of these genes (7,8).
Clinical epidemiology: the scope of CVD and
metabolic risk in Mexico
In the Third National Health and Nutrition Examination
Survey in the United States, the unadjusted and age-adjusted
prevalences of the metabolic syndrome, a complex of disor-
ders related to type 2 diabetes mellitus (TSDM), obesity, and
the risk of CVD (as deﬁned by the Third Report of The Na-
tional Cholesterol Education Program Expert Panel on De-
tection, Evaluation, and Treatment of High Blood Cholesterol
in Adults) (NCEP-III), were 21.8% and 23.7%, respectively
(9). Mexican Americans had the highest age-adjusted prev-
alence of the metabolic syndrome (31.9%) from a repre-
sentative sample of U.S. adults (10). By comparison, in a
population-based survey in the Republic of Mexico, the pre-
valence of the metabolic syndrome was 26.6% using the
NCEP-III criteria (11).
Today, Mexican Americans make up the largest Hispanic
group in the United States (66.9% of the total Hispanic
American population), followed by Central and South
Americans (14.3%), Puerto Ricans (8.6%), Cubans (3.7%),
and other Hispanics (6.5%) (12). As a group, Mexican Ameri-
cans represent a mixture of several ethnic backgrounds, mainly
Spanish-European and Native American (Amerindians).
In Mexico, obesity, T2DM, and CVD now account for
more deaths per year than infectious diseases, a change
that has been called the epidemiologic transition (13). In
1993, 7.2% of Mexican nationals ages 20 to 69 y were known
to have T2DM; by 2000 this prevalence had increased to
10.9%. The prevalence of obesity (BMI $30) increased
from 21.4–24.4% over the same period (14).
Mexicans share with Mexican Americans a prevalence of
CVD risk factors, suggesting shared genetic factors. As the
source population, Mexicans are likely to retain more of
the allelic diversity resulting from the Spanish conquest of
Mexico and subsequent conﬂuence of European and Native
American origins. To an even greater degree than Mexican
Americans, Mexican nationals have maintained the tradition
of large, extended families whose members remain in the
same geographic area, providing larger samples of related in-
dividuals for genetic analysis. Because much of our interest
is in the normal variation of phenotypes lending susceptibil-
ity to metabolic disease and CVD risk, it will be interesting
to compare the expression of these phenotypes in rapidly de-
veloping Mexico with the more economically developed
United States. As noted, obesity, T2DM, and CVD are grow-
ing public health problems in Mexico. Given historic rates of
immigration to the United States, an increase in these risk
factors in Mexico will likely affect the U.S. population as
well. In summary, the Mexican population is an appropriate
and as yet little-studied population for research on the ge-
netic epidemiology of metabolic disease in Hispanics.
Genetic studies of Mexican-American families
The Department of Genetics at Texas Biomedical Research
Institute, San Antonio, Texas, has several ongoing genetic
epidemiological studies in Mexican-American populations
including the SAFHS, the San Antonio Family Diabetes/
Gallbladder Study, and the Viva la Familia Study, which is
focused on the genetics of obesity and diabetes in Hispanic
children (5,15,16). These studies have already yielded valu-
able clues about the genetic basis of metabolic disease via
positional information from linkage and genomewide asso-
ciation. The Genética de las Enfermedades Metabólicas en
México (Genetics of Metabolic Diseases in Mexico) (GEMM)
Family Study will extend these studies to a much larger cohort
of people born and living inMexico (17,18). This will allow the
scientists to compare the effect of a shared genetic background
on both sides of the border and will also offer the potential for
finding novel genetic variants by examining a larger sample of
individuals from different regions in Mexico.
The SAFHS
Although to date there has been little genetic epidemiological
study of CVD risk factors in the Republic of Mexico, much
research has been done among Hispanics in the United States
(Mexican Americans, in particular), motivated by the ele-
vated prevalence of metabolic disease in this population sub-
group. The search for genes involved in the expression of
obesity has been one of the focal points of the SAFHS, a large,
family-based study to examine the genetics of risk of athero-
sclerosis in Mexican Americans (5). The goal is to dissect ge-
netic signals from the complex interactions of multiple
genetic and environmental factors underlying the variation
11 Abbreviations used: CVD, cardiovascular disease; GEMM, Gene´tica de las Enfermedades
Metabo´licas en Me´xico (Genetics of Metabolic Diseases in Mexico); ICC, interclass
correlation; NCEP-III, Third Report of The National Cholesterol Education Program Expert
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults; QTL,
quantitative trait loci; SAFHS, San Antonio Family Heart Study; T2DM, type 2 diabetes
mellitus.
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in phenotypes in general populations. The variance compo-
nents–based statistical methods used in the SAFHS have
been developed concurrently with, and often in direct re-
sponse to, such analysis. In brief, pedigree information and
positional marker genotypes (short tandem repeats, single
nucleotide polymorphisms, or both) are used to estimate
the degree of genetic identity between individuals, and this
is compared with their phenotypic similarity. The overall ge-
netic similarity is used to estimate the heritability, or the pro-
portion of total phenotype variance attributable to shared
genes. Information frompositionalmarkers is used to further
decompose the heritability into effects of genetic similarity at
specific genomic locations [quantitative trait loci (QTL)] and
themain effects of specific markers that may be closely linked
to functional genetic variants (19,20).
To date, genome-scanning efforts have found 2 QTLs lo-
cated on chromosomes 2 and 8 in this population that have
pronounced effects on the expression of a variety of obesity-
related phenotypes (e.g., leptin levels, fat mass, and BMI)
(21). Arya et al. (22) are currently working to further reﬁne
these signals and to identify the genes and allelic variants in-
volved. The same researchers found evidence suggesting that
the factor structures for the risk of metabolic syndrome are
inﬂuenced by multiple distinct genes across the genome.
They conducted a principal components analysis using
data on 14 phenotypes related to the risk of the development
of metabolic syndrome to explore the genetic predisposi-
tions of this complex syndrome. The subjects were 566 non-
diabetic Mexican Americans in 41 extended families from
the SAFHS. Each factor exhibited evidence of either signiﬁ-
cant or suggestive linkage involving 4 factor-speciﬁc chro-
mosomal regions on chromosomes 1, 3, 4, and 6. Signiﬁcant
evidence of linkage of the lipid factor was found on chromo-
some 4, where the cholecystokinin A receptor (CCKAR) and
ADP-ribosyl cyclase 1 (CD38) genes are located. In summary,
genetic epidemiological studies have begun to reveal the genetic
causes of CVD risk in Mexican Americans, and variance com-
ponents–based positional gene discovery is an effective tool for
understanding the genetic basis of complex phenotypes (23).
The GEMM Family Study
The GEMM study is a newly established, multicenter collab-
orative study of the genetic epidemiology of metabolic syn-
drome (17). The overall goal of this project is to identify the
genes that are involved in the development of these major
public health threats in an effort to better diagnosis and treat
those who are afﬂicted or at risk (18).
Members of the Department of Genetics at Texas Bio-
medical Research Institute provide oversight and coordina-
tion of the GEMM. The 2 participating centers in Mexico
have been selected based on their afﬁliation with a medical
university and/or teaching hospital: the Autonomous Uni-
versity of Nuevo León and the Autonomous University of
Yucatán. Both centers are currently recruiting individuals
in extended families. Volunteers are brought into a dedi-
cated diagnostic facility at each center to provide a medical
history, be measured on a variety of anthropometric and
other clinical traits relevant to metabolic diseases, provide
a blood sample for biochemical analysis and DNA for geno-
typing, provide biopsy specimens of subcutaneous fat and
muscle as a basis for genomewide expression profiling,
and provide postprandial measurements of the same traits
after a mixed-meal challenge. The entire study is projected
to take 5 y. The biochemical analysis and all the genotyping
and statistical analyses are carried out at the Texas Biomed-
ical Research Institute (17).
Current status of knowledge
Preliminary data collection in the GEMM
In early 2005, 8 medical institutions in Mexico (Ciudad Ob-
regón, Sonora; Durango, Durango; Monterrey, Nuevo León;
San Luis Potosí, S.L.P.; Celaya, Guanajuato; Mexico City;
Cuernavaca, Morelos; and Mérida, Yucatán), agreed to re-
cruit a preliminary sample of volunteers as proof of princi-
ple for collaborative collection of phenotypes and family
data. One to 5e families were recruited at each of the 8 cen-
ters. Families were recruited based on their size rather than
on any disease status. The clinical examination included ba-
sic anthropometric measures [height, BMI (kg/m2) plus a
fasting blood draw, waist circumference, and systolic and di-
astolic blood pressures]. Total serum concentrations of glu-
cose, cholesterol, and triglycerides were measured (17,18).
All the phenotypes examined were significantly heritable.
The centers recruited and examined 381 individuals (200
women and 181 men) in 21 extended families with at least 3
generations represented in each family; 34 women (17.0%)
and 29 men (16.0%) in this preliminary cohort of the
GEMM had fasting glucose levels $126 mg/dL, the cutoff
value for T2DM (American Diabetes Association fasting cri-
terion) (24). This measure provided suggestive information
about the prevalence of T2DM in this cohort. By compari-
son, in the SAFHS at initial recruitment, 14.7% of women
and 14.9% of men had T2DM according to the American
Diabetes Association 1997 criteria (24).
Table 1 presents the distribution of 4 of 5 indicators of
the metabolic syndrome (NCEP-III definition) in study par-
ticipants 20 to 59 y of age (12). It is worth noting the extent
of disease risk given that the families were not recruited with
respect to any medical condition.
Gene expression phenotype in Mexican Americans
In the SAFHS, genomewide quantitative transcriptional
proﬁles were assayed with lymphocytes from 1431 sample
subjects; complete data are available for 1240 subjects (6).
These proﬁles were obtained using an Illumina Bead Station
500 GX platform. High-quality RNA was obtained from fro-
zen lymphocyte samples collected at the ﬁrst examination pe-
riod w10 y earlier. Of 47,289 transcripts probed by the
Sentrix Human-6 Expression BeadChip (Illumina), 20,413
had signal significantly above background. Of these, 20,228
exhibited experiment-wide significant heritabilities.
Using variance component–based quantitative trait link-
age analysis, 915 cis-regulated QTLs were identified in the
SAFHS data, i.e., loci at which there is experiment-wide
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significant evidence of variation near the transcript’s ge-
nomic location that influences expression level. The average
LOD score for these significant cis-acting QTLs is 5 with
some LOD scores >40 (6).
Similarly, there is evidence of 1688 trans-acting QTLs
that influence expression for T2DM and obesity (3,4).
This data set is extremely useful when prioritizing posi-
tional candidate genes because phenotypes showing link-
age can be examined for correlations with transcripts
within the observed region of linkage. Additionally, the
presence of cis-acting QTLs for transcripts within a previ-
ously identified linkage region that exhibit correlation with
the focal (linked) phenotype can be viewed as indepen-
dently supported strong candidate genes.
Example: positional-transcriptional candidate gene
for HDL levels
To test the utility of the gene expression phenotypes for gene
discovery, levels of HDL cholesterol in 1240 SAFHS partici-
pants were correlated with levels of the cis-regulated tran-
scripts (6). VNN1 stood out as a gene that showed very
strong evidence of both cis regulation and correlation with
HDL; bivariate analysis of VNN1 expression and HDL
showed genetic correlation of 0.28. VNN1 encodes pante-
theinase, an enzyme required for synthesis of the antioxidant
cyteamine. Resequencing of the VNN1 promoter identified
4 single nucleotide polymorphisms strongly associated
with VNN1 expression and HDL levels (6). Further molec-
ular dissection of this locus is ongoing.
Comparative proﬁles of lymphocytes, muscle, and
adipose tissue in the GEMM: correlation and reliability
of synchronous in vivo gene expression in 3 human
tissues
Our current recruitment has assayed genomewide gene ex-
pression in lymphocytes and biopsy specimens of skeletal
muscle and subcutaneous fat in 4 healthy adult men in Mon-
terrey, Mexico, 2 lean (BMI <25) and 2 obese (BMI >30 kg/m2).
We obtained RNA samples from lymphocytes and biopsy
specimens of quadriceps muscle and subcutaneous fat, 3 tis-
sues relevant to inflammation, obesity, insulin resistance,
and T2DM, from these healthy men (25). A similar inter-
vention was done with 4 women in Mérida, Yucatan
(unpublished data). The women were 33 to 37 y of age. Inclu-
sion criteria were normotensive, not known to have diabetes
or other chronic disease, not taking medication for hyperten-
sion or hyperlipidemia, and without symptoms of infection
or acute inflammation. They gave informed consent. Re-
cruitment, examination, and biopsies were carried out
with approval of the Ethics Committee of the Autonomous
University of Nuevo León, Monterrey, Mexico. Analysis of
blood and tissue samples was performed at Texas Biomedical
Research Institute with approval of the Institutional Review
Board of the University of Texas Health Science Center at
San Antonio (26). The subjects were examined while in a
fasting state. Measurements were made of Blood pressure,
height, weight, body composition by bioimpedance, hemo-
globin A1c, and fasting plasma glucose measurement were
performed. Medical staff collected 3 mL of whole blood
and biopsy specimens of subcutaneous abdominal fat and
quadriceps muscle under local anesthesia. All subjects un-
derwent follow-up examinations at 2 and 5 d after the pro-
cedure, and all recovered as expected (26).
Statistical analyses were performed in R (27). Expression
signals were standardized as Z-scores as described (6,26) to
minimize variation due to differences in sample RNA yield.
For calculation of intraclass correlation (ICC), the 4 individ-
ual measures of each transcript in each tissue type were
Z-scored again to minimize the effect of overall differences
inmean expression between tissues whilemaintaining weighted
ranks of individual expression levels. ICC, a common measure
of reliability of repeated measures (28), is a comparison of
within-individual variation with total variation and has a theo-
retical distribution (21/(k 2 1), 1) where k is the number of
repeated measures (29). A negative value of ICC indicates
much greater within- than between-individual variance or
very poor agreement between repeated measures (in contrast
to the Pearson’s correlation, for which 21 = r << 0 implies
inverse association).
We used the IlluminaHuman-6 v2 BeadChip for theMon-
terrey pilot. All samples provided ample good-quality RNA
for ampliﬁcation and microarray analysis, which required
1.5 mg of amplified RNA per sample (Table 2). Total RNA
was queried by microarray for expression of >48,000 tran-
scripts representing validated genes as well as predicted genes
and pseudogenes. Expression signals were standardized within
each tissue type to remove stochastic variability in sampleRNA
yield (26). For each tissue type, transcripts with signal above
controls at a nominal P < 0.05 in every sample were classed
as “detectable” (in the full study, we expect a given transcript
might fail to be detectable in some samples). By this criterion,
of 48,687 targets queried, detectionwas 30.9% in lymphocytes,
28.4% in muscle, and 30.8% in adipose tissue. Detection rates
per sample were higher (range, 32.8–39.9; Table 2) (25).
These results in a small sample compare acceptably to an
overall detection rate, by somewhat different criteria, of
43.1% in 1240 lymphocyte samples in the SAFHS (6).
A total of 17,128 gene transcripts were detectable above
background in every subject in at least 1 tissue type (25).
Of these, 78.6% were detectably expressed in $2 tissues,
Table 1. Metabolic syndrome risk factors in women and men
aged 20–59 y: Genética de las Enfermedades Metabólicas en
México (Genetics of Metabolic Diseases in Mexico) preliminary
sample1,2
NCEP-III criterion Women Men
Waist .88 cm (women),
.102 cm (men)
65/162 (40.1) 41/143 (28.7)
Systolic BP $130 or
diastolic BP $85 mm Hg
52/162 (32.1) 69/144 (47.9)
Triglycerides $150 mg/dL 42/148 (28.4) 69/133 (52.9)
Fasting glucose $110 mg/dL 29/161 (18.0) 29/143 (20.3)
1 Data given as number affected/total number (%).
2 BP, blood pressure; NCEP-III, Third Report of The National Cholesterol Education Pro-
gram Expert Panel on Detection, Evaluation, and Treatment of High Blood Choles-
terol in Adults.
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61.3% in all 3 (Fig. 1). For all detectable transcripts in each
pairwise comparison of tissues, Pearson’s correlations of
mean transcript expression levels were lymphocyte-fat, r =
0.75 6 0.006, 11,840 (point estimate 6 SE, n transcripts);
lymphocyte-muscle, r = 0.61 6 0.008, 10,914; muscle-fat,
r = 0.69 6 0.007, 11,707. Per transcript, w4–6% of genes
showed significantly correlated expression (|r| > 0.95 for
4 observations per tissue, 2 df): lymphocyte-fat, 545 (4.60%);
lymphocyte-muscle, 634 (5.81%); muscle-fat, 461 (3.94%).
Given our sample size, we expect that these are minimum es-
timates of per-transcript correlation. Mean RNA levels were
correlated between tissue types (range, r = 0.61–0.75) (25).
For individual genes, we estimated the reliability of expres-
sion across tissues as the ICC and found that patterns of indi-
vidual variation in expression were maintained across tissues
for many genes. Transcript reliability was correlated with ev-
idence of cis regulation, suggesting that the effects of proximal
sequence variants may be especially consistent in different
cellular environments (25,26).
Despite this substantial correlation across tissues, there
were some striking examples of tissue speciﬁcity in expres-
sion. For example, the transcript of the leptin gene LEP
was not detectable in lymphocytes, expressed at low levels
in muscle, but expressed at high levels in fat; the latter ex-
pression was almost perfectly correlated with subject adipos-
ity, increasing w1 SD per 10 kg/m2 increase in BMI (26).
We also examined within- and between-tissue correlation
of lymphocyte expression of TNF (TNFA), GHRL (ghrelin),
and PPARG, 3 cytokines of interest for their effects on in-
flammation, and computed Pearson’s correlations with ex-
pression in all 3 tissues. Even in this small sample, we
found a substantial number of correlations with absolute
values $80% (Table 3). We then used Ingenuity Pathways
analysis to classify the correlated sets by gene function.
Figure 2 shows the top 10 functional classes for each focal
transcript. There is considerable consistency in functional
assignment across tissues. Interestingly, the rank order of
functional assignments is quite similar for TNF and ghrelin;
lymphocyte expression of these is fully negatively correlated
(r = 21), consistent with the function of the gene products
(TNF is generally proinflammatory, and ghrelin is anti-
inflammatory).
The genetic analysis of gene expression naturally leads to
the classiﬁcation of QTLs into cis-acting and trans-acting
classes based on the relative genomic locations of the tran-
script and its QTL (30,31). For comparison of ICC with
the pattern of gene regulation, we used the SAFHS data on
cis and trans regulation (6). This comparison was necessarily
limited to the subset of transcripts that were detectable in
SAFHS and in all 3 tissues in GEMM and that showed nom-
inal evidence (P < 0.05) of heritability in SAFHS. The cis ef-
fect size was defined as the proportion of total variance in
transcript expression due to allele sharing at the start posi-
tion of the respective structural gene, with positions estab-
lished by public genomic data. The trans effect size was
defined as the highest positional effect size on any chromo-
some other than the one bearing the structural gene.
In SAFHS, linkage analysis identiﬁed 750 transcripts with
nominal genomewide evidence of cis regulation (i.e., the
strongest evidence of linkage localized to their structural
genes) and 1075 trans-regulated (strongest linkage elsewhere
in genome) (6). Results from animal models suggest that ef-
fects of cis variants may be especially consistent across tis-
sues, so we hypothesized that cis regulation would enhance
reliability (32). In 5443 transcripts that were detectable in
Table 2. Characteristics of the Monterrey biopsy study participants1,2
ID
Clinical
measurements
Total RNA
concentration
% of Detection
of transcripts
Age, y Weight, kg BMI BP s/d HbA1c % Fat Lymph Musc Adip Lymph Musc Adip
A 34 63.7 20.3 100/70 4.8 12.20 3.96 75.27 43.82 35.2 34.6 39.9
B 33 65.5 24.4 110/86 5.2 21.70 12.91 60.56 26.94 36.0 32.9 38.7
C 33 105.2 35.6 136/90 5.0 38.30 14.66 158.40 52.60 35.7 34.5 35.6
D 37 132.2 41.3 126/90 5.4 36.30 9.89 179.00 32.64 35.8 32.8 39.2
1 Percentage of body fat mass (Fat, %) was measured by bioimpedance. RNA concentration: mg/mL whole blood (lymphocytes) or ng/mg
tissue (muscle and adipose); % detection of transcripts at P , 0.05 (see text).
2 BP s/d, blood pressure systolic/diastolic; HbA1c, hemoglobin A1c; ID, identifier; Lymph, lymphocyte; Musc, muscle; Adip, subcutaneous ad-
ipose tissue.
Figure 1. The numbers of transcripts detectable above
background; most genes were detectable in $2 tissue types.
Table 3. Percentage of detectable transcripts correlated with
focal genes (|r| $80%) by tissue type1
Focal transcript Lymphocyte Muscle Adipose
TNF 65.8 49.4 10.5
GHRL 68.9 77.9 9.2
PPARG 82.4 13.8 20.2
1 GHRL, ghrelin; PPARG, peroxisome proliferator–activated receptor g.
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both SAFHS and GEMM, transcript reliability in GEMM
was positively correlated with the effect size of cis variants
in SAFHS (Fig. 3). The pool of highly reliable transcripts
(ICC = 0.6, 3 tissues) was enriched for cis-regulated genes
relative to the rest (Fisher’s exact test: OR = 2.41, P =
0.0000006) (28). We found no similar enrichment for
trans-regulated genes (OR = 1.24, P = 0.19). The latter
test is an important control for the possibility that the joint
identification of transcripts is reliable and cis-regulated was
simply an artifact of signal strength because the level of sig-
nificance (LOD score = 3, P = 0.0001) was the same for both
cis and trans linkage.
Conclusions
The completion of the Human Genome Project has given re-
searchers the potential to reveal the genetic contribution to
Figure 2. Ingenuity Pathway Analysis
functional class assignments for
correlated transcripts. Ingenuity Pathway
Analysis A is a powerful curated
database and analysis system for
understanding how proteins work
together to effect cellular changes. We
use this system to classify the correlated
sets by gene function. The top 10
functional classes for each focal
transcript are shown. There is
considerable consistency in functional
assignment across tissues. GHRL, ghrelin;
TNF, tumor necrosis factor; PPARG,
peroxisome proliferator-activated
receptor gamma
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major public health problems such as heart disease, diabetes,
and obesity. However, ﬁnding the individual genetic variants
that contribute to the development of disease will be a very
difﬁcult task due to the variability in disease genes and their
expression in humans (33).
Cardiovascular and metabolic diseases develop as a con-
sequence of a complex cascade of events. An individual in-
herits a set of alleles (genotype) from his or her parents
and, in combination with environmental factors (lifestyle),
these determine physiological states such as lipoprotein
levels, adiposity, and immune functions. These, in turn,
can result in abnormalities such as vessel wall dysfunction,
hypertension, and insulin resistance. Over many years, these
factors inﬂuence the development of chronic diseases such
as diabetes, kidney disease, atherosclerosis, and myocardial
infarction. Most of these interactions are likely to be inﬂu-
enced by genetic factors.
Most studies of metabolic and cardiovascular disorders to
date have used a classic ‘‘one gene at a time’’ approach. This
approach has been very successful in clarifying Mendelian
traits such as familial hypercholesterolemia. However, com-
plex traits such as the common forms of atherosclerosis pre-
sent special problems. In particular, it is likely that most
complex diseases result from the interactions of multiple
genes and, therefore, cannot be realistically modeled by sin-
gle-gene perturbations. One promising solution involves the
combination of natural genetic variation and expression ar-
ray analysis, sometimes referred to as global gene expression
profiling or genetical genomics (34). The measurement of
transcript levels in populations allows the identification of
coregulated genes and relationships between transcript levels
and clinical traits. In addition, this integrative approach re-
lates DNA variation to transcript abundance, allowing identi-
fication of primary (cis-acting) and secondary (trans-acting)
effects controlling transcript abundance (35).
The GEMM Family Study will provide an opportunity to
compare synchronous gene expression in multiple tissues
relevant to the metabolic syndrome (17,25). Although we
expect some degree of tissue speciﬁcity in expression, our
preliminary results suggest that individual variation in
gene regulation is consistent across tissues for many genes.
Although tissue-speciﬁc differences are expected for some
genes, many others should exhibit correlated patterns of
expression across tissues. This correlation could take
2 forms: 1) mean levels of expression could be correlated
across tissues (i.e., a gene that is highly expressed relative
to others in one tissue may be similarly ranked in another)
or, perhaps of more direct interest to us as genetic epidemi-
ologists, 2) the relative ranking of individual expression for a
given gene could be maintained across tissues. Because of
the direct regulatory effect of proximal variants, it may be
easier to detect this type of correlation in cis-regulated genes.
For genetic analysis, we were especially interested in
genes whose relative ranks of individual variation in lym-
phocyte expression levels most reliably predicted rank order
in other tissues. We treated the 3 tissue types as repeated
within-individual measures of expression and computed
the reliability of each transcript as its ICC (28,29). In con-
trast to Pearson’s r—the ICC in Fisher’s terminology—the
ICC assumes that repeated measures are drawn from the
same distribution; when this assumption is justified, the
ICC should be a more accurate measure of association
than r because it is based on fewer df (28). Also unlike r,
the ICC is not limited to pairwise comparisons. For all 3 tis-
sues, w10% of transcripts had an ICC = 0.6; this is a sug-
gested reliability threshold for the ICC and corresponded
in our sample to a transcript-wise P = 0.048 (29). Not sur-
prisingly for biological reasons, reliability was greater in
pairwise comparisons: lymphocyte-fat, 29.2% with an ICC
= 0.6; lymphocyte-muscle, 23.1% with ICC $ to 0.06 for
both comparisons. Again, given our sample size, we expect
that these are minimum estimates of reliability.
Bioinformatic analysis showed that the reliable tran-
scripts represented a broad range of functions not limited
to housekeeping genes (36). The pool of highly reliable tran-
scripts (ICC = 0.6, 3 tissues) was enriched for genes related
to immunity, development, and metabolic disease, whereas
the least reliable transcripts were enriched for genes with tis-
sue-speciﬁc functions (e.g., connective tissue development)
or related to cell turnover/cell death (Fig. 4). The latter rela-
tionship may reflect the higher turnover rate of lymphocytes
relative to the other tissue types.
Comparison of gene expression across tissues is an area of
intense research for a wide variety of purposes. Expression of
speciﬁc obesity-related genes (leptin, adiponectin, PPARg,
FAT/CD36, andHSD) has beenmeasured recently in samples
of abdominal subcutaneous, omental, and mesenteric adi-
pose tissue acquired during gastric bypass surgery in 18 obese
patients (37). The comparison of interest in this case was ex-
pression in each depot in diabetic versus nondiabetic pa-
tients; except for adiponectin, the mean expression levels in
mesenteric fat were significantly up-regulated in diabetes.
Neither individual differences in expression nor concordance
among fat depots were reported. Numerous investigators
have sought to develop networks of coexpressed genes to de-
fine functional pathways (38,39). Using banked tissue
Figure 3. Selected functional comparisons of the top 10%
(gray bars) and bottom 10% (black bars) of transcripts ranked by
intraclass correlation coefficient. Bar height indicates relative
enrichment for genes of a given functional class.
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samples, expression profiles of RNA from 24 human tissues
have been analyzed to identify clusters of coexpression related
to gene function; this study includes considerable investiga-
tion of analytical methods (40). The banked tissues are pre-
sumably from different individuals, and samples were
pooled; consequently, any evidence of individual variation
in expression is absent from these data (and was, of course,
not a focus of the study).
In addition to the international beneﬁts of the GEMM
Family Study to both Mexico and the United States in terms
of biomedical research and health care, the study is structured
to enhance the scientiﬁc capacity of the centers in Mexico by
providing new equipment, technical training, and research
opportunities for Mexican investigators in collaborative pro-
jects usingGEMMdata. Establishment of the diagnostic facil-
ities will involve providing equipment and training to the
centers. On completion of the data collection for GEMM,
these resources will bemade available to the sponsoring insti-
tutions for future medical research and diagnostic work.
The long-term aim of this project is to study gene expres-
sion before and after a well-deﬁned meal to characterize
normal variation in postprandial metabolism. This expres-
sion proﬁling is expected to ﬁnd genes contributing to the
metabolic ﬂexibility of individuals in the Mexican popula-
tion, by using the latest advances in genomic science focused
on studies based on an integrated systems approach to hu-
man biology. Such a focus on the genetic response following
the consumption of a nutritionally deﬁned meal at the level
of the speciﬁc tissues involved (i.e., fat and muscle), will pro-
duce new insights into the genetic architecture of individual
variation in metabolism of carbohydrates, fats and proteins.
It will also shed light on how this variation in response re-
lates to the risk of a variety of chronic diseases including
obesity, diabetes, and heart disease. Although signiﬁcant
challenges remain in the interpretation of large-sample ex-
pression data, such data will be crucial for the formal inte-
gration of positional and transcriptomic information (41).
This integrative global gene expression proﬁling ap-
proach is proving extremely useful for identifying genes
and pathways that contribute to complex clinical traits.
Clearly, the coincidence of clinical trait QTL and expression
QTL can help in the prioritization of positional candidate
genes. More important, mathematical modeling of correla-
tions between levels of transcripts and clinical traits can al-
low the identiﬁcation of master key regulatory genes and
provide the data needed to develop models of biological net-
works that better explain disease pathogenesis of complex
traits such as CVD, T2DM, and obesity.
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